These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38553520)

  • 1. Evaluating convolutional neural network-enhanced electrocardiography for hypertrophic cardiomyopathy detection in a specialized cardiovascular setting.
    Hirota N; Suzuki S; Motogi J; Umemoto T; Nakai H; Matsuzawa W; Takayanagi T; Hyodo A; Satoh K; Arita T; Yagi N; Kishi M; Semba H; Kano H; Matsuno S; Kato Y; Otsuka T; Uejima T; Oikawa Y; Hori T; Matsuhama M; Iida M; Yajima J; Yamashita T
    Heart Vessels; 2024 Jun; 39(6):524-538. PubMed ID: 38553520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Hypertrophic Cardiomyopathy Using a Convolutional Neural Network-Enabled Electrocardiogram.
    Ko WY; Siontis KC; Attia ZI; Carter RE; Kapa S; Ommen SR; Demuth SJ; Ackerman MJ; Gersh BJ; Arruda-Olson AM; Geske JB; Asirvatham SJ; Lopez-Jimenez F; Nishimura RA; Friedman PA; Noseworthy PA
    J Am Coll Cardiol; 2020 Feb; 75(7):722-733. PubMed ID: 32081280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saliency maps provide insights into artificial intelligence-based electrocardiography models for detecting hypertrophic cardiomyopathy.
    Siontis KC; Suárez AB; Sehrawat O; Ackerman MJ; Attia ZI; Friedman PA; Noseworthy PA; Maanja M
    J Electrocardiol; 2023; 81():286-291. PubMed ID: 37599145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of patients with dilated phase of hypertrophic cardiomyopathy using a convolutional neural network applied to multiple, dual, and single lead electrocardiograms.
    Hirota N; Suzuki S; Motogi J; Umemoto T; Nakai H; Matsuzawa W; Takayanagi T; Hyodo A; Satoh K; Arita T; Yagi N; Kishi M; Semba H; Kano H; Matsuno S; Kato Y; Otsuka T; Uejima T; Oikawa Y; Hori T; Matsuhama M; Iida M; Yajima J; Yamashita T
    Int J Cardiol Heart Vasc; 2023 Jun; 46():101211. PubMed ID: 37152425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Automatic detection model of hypertrophic cardiomyopathy based on deep convolutional neural network].
    Bu Y; Cha X; Zhu J; Su Y; Lai D
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2022 Apr; 39(2):285-292. PubMed ID: 35523549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of a Convolutional Neural Network and Explainability Technique for 12-Lead Electrocardiogram Interpretation.
    Hughes JW; Olgin JE; Avram R; Abreau SA; Sittler T; Radia K; Hsia H; Walters T; Lee B; Gonzalez JE; Tison GH
    JAMA Cardiol; 2021 Nov; 6(11):1285-1295. PubMed ID: 34347007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrocardiographic voltage criteria in patients with hypertrophic cardiomyopathy.
    Monzo L; Martino A; Lanzillo C; Bencivenga S; Acitelli A; Fedele E; Salustri E; Bona RD; Maresca L; Silvetti E; Canestrelli S; Minati M; Penco M; Calò L
    J Cardiovasc Med (Hagerstown); 2020 Sep; 21(9):696-703. PubMed ID: 32639329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A diagnostic method for cardiomyopathy based on multimodal data.
    Shen L; Zhang X; Huang S; Wu B; Li J
    Biomed Tech (Berl); 2023 Aug; 68(4):411-420. PubMed ID: 37013592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Model for classification of heart failure severity in patients with hypertrophic cardiomyopathy using a deep neural network algorithm with a 12-lead electrocardiogram.
    Togo S; Sugiura Y; Suzuki S; Ohno K; Akita K; Suwa K; Shibata SI; Kimura M; Maekawa Y
    Open Heart; 2023 Dec; 10(2):. PubMed ID: 38056911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large Q and S waves in lead III on the electrocardiogram distinguish patients with hypertrophic cardiomyopathy from athletes.
    Chen AS; Bent RE; Wheeler M; Knowles JW; Haddad F; Froelicher V; Ashley E; Perez MV
    Heart; 2018 Nov; 104(22):1871-1877. PubMed ID: 29680808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional Deep Convolutional Neural Networks for Automated Myocardial Scar Quantification in Hypertrophic Cardiomyopathy: A Multicenter Multivendor Study.
    Fahmy AS; Neisius U; Chan RH; Rowin EJ; Manning WJ; Maron MS; Nezafat R
    Radiology; 2020 Jan; 294(1):52-60. PubMed ID: 31714190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How are ECG parameters related to cardiac magnetic resonance images? Electrocardiographic predictors of left ventricular hypertrophy and myocardial fibrosis in hypertrophic cardiomyopathy.
    Dohy Z; Vereckei A; Horvath V; Czimbalmos C; Szabo L; Toth A; Suhai FI; Csecs I; Becker D; Merkely B; Vago H
    Ann Noninvasive Electrocardiol; 2020 Sep; 25(5):e12763. PubMed ID: 32329134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ST-segment depression as a risk factor in hypertrophic cardiomyopathy.
    Haghjoo M; Mohammadzadeh S; Taherpour M; Faghfurian B; Fazelifar AF; Alizadeh A; Rad MA; Sadr-Ameli MA
    Europace; 2009 May; 11(5):643-9. PubMed ID: 19164362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accurate diagnosis of apical hypertrophic cardiomyopathy using explainable advanced electrocardiogram analysis.
    Hughes RK; Thornton GD; Malcolmson JW; Pierce I; Khoury S; Hornell A; Knott K; Captur G; Moon JC; Schlegel TT; Ugander M
    Europace; 2024 Mar; 26(4):. PubMed ID: 38588067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel electrocardiographic features in carriers of hypertrophic cardiomyopathy causing sarcomeric mutations.
    Jalanko M; Heliö T; Mustonen P; Kokkonen J; Huhtala H; Laine M; Jääskeläinen P; Tarkiainen M; Lauerma K; Sipola P; Laakso M; Kuusisto J; Nikus K
    J Electrocardiol; 2018; 51(6):983-989. PubMed ID: 30497761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of ECG findings to phenotypic expression in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study.
    Delcrè SD; Di Donna P; Leuzzi S; Miceli S; Bisi M; Scaglione M; Caponi D; Conte MR; Cecchi F; Olivotto I; Gaita F
    Int J Cardiol; 2013 Aug; 167(3):1038-45. PubMed ID: 22464482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of ECG to differentiate apical hypertrophic cardiomyopathy from non-ST elevation acute coronary syndrome.
    Tao Y; Xu J; Bako SY; Yao X; Yang D
    BMC Cardiovasc Disord; 2020 Jun; 20(1):306. PubMed ID: 32576233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram.
    McLeod CJ; Ackerman MJ; Nishimura RA; Tajik AJ; Gersh BJ; Ommen SR
    J Am Coll Cardiol; 2009 Jul; 54(3):229-33. PubMed ID: 19589435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study analyzing automated ECG screening of hypertrophic cardiomyopathy.
    Campbell MJ; Zhou X; Han C; Abrishami H; Webster G; Miyake CY; Sower CT; Anderson JB; Knilans TK; Czosek RJ
    Heart Rhythm; 2017 Jun; 14(6):848-852. PubMed ID: 28193509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of hypertrophic cardiomyopathy is improved when using advanced rather than strictly conventional 12-lead electrocardiogram.
    Potter SL; Holmqvist F; Platonov PG; Steding K; Arheden H; Pahlm O; Starc V; McKenna WJ; Schlegel TT
    J Electrocardiol; 2010; 43(6):713-8. PubMed ID: 21040828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.